| Literature DB >> 2334211 |
Abstract
Seven patients with cystic fibrosis taking high doses of pancreatin supplements were assessed to determine whether this dose was necessary to achieve adequate fat absorption. Patients reduced their intake from a group mean of 45 to 21 capsules a day. Five patients did not have any significant alteration in fat malabsorption while taking the reduced enzyme dose.Entities:
Mesh:
Substances:
Year: 1990 PMID: 2334211 PMCID: PMC1792276 DOI: 10.1136/adc.65.3.311
Source DB: PubMed Journal: Arch Dis Child ISSN: 0003-9888 Impact factor: 3.791